Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds IVC.
No tracked institution reports a position in IVC as of their last filing.
No one on the platform has traded IVC yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 2 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-05-08 | $-0.55 | $-1.08 | -96.8% |
| 2022-11-07 | $-0.39 | $-0.92 | -135.9% |
| 2022-08-08 | $-0.42 | $-0.62 | -47.6% |
| 2022-05-09 | $-0.43 | $-0.69 | -60.5% |
| 2022-03-08 | $0.02 | $0.08 | +300.0% |
| 2021-10-27 | $-0.19 | $-0.12 | +36.8% |
| 2021-08-04 | $-0.23 | $-0.28 | -21.7% |
| $39M |
| — |
| FRLNFreeline Therapeutics Holdings plc | $6.49 | +0.15% | $28M | — |
| LSBLakeShore Biopharma Co., Ltd | $0.63 | +0.00% | $26M | — |
Source: Financial Modeling Prep · peers by sector/industry